Literature DB >> 8496076

Costs of clinical mastitis and mastitis prevention in dairy herds.

G Y Miller1, P C Bartlett, S E Lance, J Anderson, L E Heider.   

Abstract

A stratified random sample of 50 Ohio dairy herds, monitored for 1 year between March 1988 and May 1989, was used to estimate the component costs of clinical mastitis per cow-year overall and by organism, the component costs of an episode of clinical mastitis overall and by organism, and the incidence of clinical mastitis by organism. Each herd was visited monthly by a veterinarian who conducted on-farm interviews and completed standardized data-collection forms designed to elicit economic information about the on-farm costs of clinical mastitis and mastitis prevention. Producers collected milk samples prior to treatment of clinical mastitis cases. Culturing methods allowed identification of 18 specific mastitis pathogen classifications. Annual costs estimated were on a per cow-year and clinical episode basis. The monthly mean population of cows monitored was 4,068. Mastitis prevention cost $14.50/cow-year, whereas the cost incurred by producers because of clinical cases of mastitis was $37.91. Organisms prevalent in the cows' environment caused the most costly types of mastitis. Disregarding contaminated samples and episodes for which no milk samples were taken, mastitis for which 2 organisms were isolated accounted for 35.5% of costs of clinical mastitis, followed by cases for which Escherichia coli (21.3%) was isolated, cases for which culturing yielded no growth (8.6%), and cases for which esculin-positive Streptococcus spp (6.4%), Klebsiella spp (5.7%), esculin-negative CAMP-negative Streptococcus spp (5.1%), Enterobacter spp (4.8%), coagulase-negative Staphylococcus spp (4.1%), coagulase-positive Staphylococcus spp (3.0%), S agalactiae (2.5%), and Bacillus spp (1.2%) were isolated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8496076

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  12 in total

1.  Concentrations of IL-6 in serum and whey from healthy and mastitic cows.

Authors:  K Hagiwara; H Yamanaka; K Hisaeda; S Taharaguchi; R Kirisawa; H Iwai
Journal:  Vet Res Commun       Date:  2001-02       Impact factor: 2.459

2.  Mannose-binding lectin 1 haplotypes influence serum MBL-A concentration, complement activity, and milk production traits in Chinese Holstein cattle.

Authors:  Jianbo Liu; Zhihua Ju; Qiuling Li; Jinming Huang; Rongling Li; Jiangbin Li; Lijuan Ma; Jifeng Zhong; Changfa Wang
Journal:  Immunogenetics       Date:  2011-06-22       Impact factor: 2.846

3.  Assessment of lactate dehydrogenase, alkaline phosphatase and aspartate aminotransferase activities in cow's milk as an indicator of subclinical mastitis.

Authors:  H Babaei; L Mansouri-Najand; M M Molaei; A Kheradmand; M Sharifan
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

4.  Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice.

Authors:  Rongfeng Cao; Kaiqiang Fu; Xiaopei Lv; Weishi Li; Naisheng Zhang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

5.  Assessment of bovine mammary chemokine gene expression in response to lipopolysaccharide, lipotechoic acid + peptidoglycan, and CpG oligodeoxynucleotide 2135.

Authors:  Jeremy A Mount; Niel A Karrow; Jeff L Caswell; Herman J Boermans; Ken E Leslie
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

6.  Association of California Mastitis Test Scores with Intramammary Infection Status in Lactating Dairy Cows Admitted to a Veterinary Teaching Hospital.

Authors:  S A Kandeel; D E Morin; C D Calloway; P D Constable
Journal:  J Vet Intern Med       Date:  2017-12-09       Impact factor: 3.333

7.  Cellular and soluble components decrease the viable pathogen counts in milk from dairy cows with subclinical mastitis.

Authors:  Tomoko Koshiishi; Masako Watanabe; Hajime Miyake; Keiichi Hisaeda; Naoki Isobe
Journal:  J Vet Med Sci       Date:  2017-07-07       Impact factor: 1.267

8.  Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells.

Authors:  Jin-Lun Lai; Yu-Hui Liu; Yong-Chong Peng; Pan Ge; Chen-Fei He; Chang Liu; Ying-Yu Chen; Ai-Zhen Guo; Chang-Min Hu
Journal:  Mediators Inflamm       Date:  2017-02-01       Impact factor: 4.711

9.  The T Cell Response to Staphylococcus aureus.

Authors:  Barbara M Bröker; Daniel Mrochen; Vincent Péton
Journal:  Pathogens       Date:  2016-03-17

10.  The anti-biofilm effect of silver-nanoparticle-decorated quercetin nanoparticles on a multi-drug resistant Escherichia coli strain isolated from a dairy cow with mastitis.

Authors:  Lumin Yu; Fei Shang; Xiaolin Chen; Jingtian Ni; Li Yu; Ming Zhang; Dongdong Sun; Ting Xue
Journal:  PeerJ       Date:  2018-10-16       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.